Intubation Checklist for Intubation, Intratracheal

Phase-Based Progress Estimates
Community Medical Center, Toms River, NJ
Intubation, Intratracheal+2 More
Intubation Checklist - Other
All Sexes
What conditions do you have?

Study Summary

To assess the ongoing continuous quality improvement of rapid sequence intubation in our emergency department. Ongoing assessment will address standardization of the process and protocol driven measures that will improve the overall quality of the intervention.

Eligible Conditions

  • Intubation, Intratracheal
  • Rapid Sequence Induction and Intubation
  • Checklist

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 11 Secondary · Reporting Duration: At time of intubation

At time of intubation
Aspiration rate
Cardiac arrest
Cuff Leak
Dental trauma
Esophageal intubation
First Pass Success Rate
Mainstem intubation
Post procedural hypotension
Unplanned extubation

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

1 of 2
1 of 2
Active Control
Experimental Treatment

700 Total Participants · 2 Treatment Groups

Primary Treatment: Intubation Checklist · No Placebo Group · N/A

Experimental Group · 1 Intervention: Intubation Checklist · Intervention Types: Other
ActiveComparator Group · 1 Intervention: Standard Care · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: at time of intubation

Trial Background

Prof. Greg Neyman, Sub-Investigator, Clinical Professor
Principal Investigator
Community Medical Center, Toms River, NJ
Closest Location: Community Medical Center · Toms River, NJ
2013First Recorded Clinical Trial
1 TrialsResearching Intubation, Intratracheal
162 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.